Vancomycin tolerance in clinical and laboratory Streptococcus pneumoniae isolates depends on reduced enzyme activity of the major LytA autolysin or cooperation between CiaH histidine kinase and capsular polysaccharide.
about
Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New AntimicrobialsIn vitro bactericidal and bacteriolytic activity of ceragenin CSA-13 against planktonic cultures and biofilms of Streptococcus pneumoniae and other pathogenic streptococci.Inspecting the potential physiological and biomedical value of 44 conserved uncharacterised proteins of Streptococcus pneumoniaeDetermination of vancomycin minimum inhibitory concentration for ceftazidime resistant Streptococcus pneumoniae in IranThe sensor histidine kinase RgfC affects group B streptococcal virulence factor expression independent of its response regulator RgfA.Coordinate regulation of Gram-positive cell surface components.Glycopeptide resistance in gram-positive cocci: a review.Toxin-antitoxin genes of the Gram-positive pathogen Streptococcus pneumoniae: so few and yet so many.In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases.Fluorescence Imaging of Streptococcus pneumoniae with the Helix pomatia agglutinin (HPA) As a Potential, Rapid Diagnostic Tool.Transcriptional Repressor PtvR Regulates Phenotypic Tolerance to Vancomycin in Streptococcus pneumoniae.New Aspects of the Interplay between Penicillin Binding Proteins, murM, and the Two-Component System CiaRH of Penicillin-Resistant Streptococcus pneumoniae Serotype 19A Isolates from HungaryPleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune responseLytA, major autolysin of Streptococcus pneumoniae, requires access to nascent peptidoglycan.The and Toxin-Antitoxin Operons Participate in Oxidative Stress and Biofilm Formation
P2860
Q26744448-ABDC63EB-A6E8-4E81-B04C-56A2F72CC668Q33874753-20E8A294-22DE-494D-96AF-C4F311564F52Q34085006-FCF51899-C879-4D07-AE55-097680B8A773Q34667511-246B269C-4A33-4F93-A6CC-17C94ADC18BDQ35098179-C444961D-E56A-40F8-8EB4-62B0FAE82054Q35873820-059D1764-C208-4EC3-835E-5A467DBC749DQ36072225-7A1A511B-B223-42C0-B4C2-9B532AA72C4DQ38064401-36303733-B947-44E8-BD9C-7ADF18077469Q38282910-9E800025-C5A6-480F-93F9-EB73EBA72574Q40109071-72274835-75FE-417E-A915-33F35FA2C3C7Q40220862-D990AC44-6102-4B04-B781-7B2B671E70D0Q41023546-211992E7-93A5-4A2F-8941-94D98CBF1A47Q41658036-F0CEDDEB-0A74-4AA6-8FE4-9FD8C1179BBBQ42133831-D4521384-0A53-48D3-A95B-55499F2131C3Q58723244-6E808B00-1FCE-48C3-8525-47290B97681C
P2860
Vancomycin tolerance in clinical and laboratory Streptococcus pneumoniae isolates depends on reduced enzyme activity of the major LytA autolysin or cooperation between CiaH histidine kinase and capsular polysaccharide.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Vancomycin tolerance in clinic ...... e and capsular polysaccharide.
@en
Vancomycin tolerance in clinic ...... e and capsular polysaccharide.
@nl
type
label
Vancomycin tolerance in clinic ...... e and capsular polysaccharide.
@en
Vancomycin tolerance in clinic ...... e and capsular polysaccharide.
@nl
prefLabel
Vancomycin tolerance in clinic ...... e and capsular polysaccharide.
@en
Vancomycin tolerance in clinic ...... e and capsular polysaccharide.
@nl
P2860
P1476
Vancomycin tolerance in clinic ...... e and capsular polysaccharide.
@en
P2093
Ernesto García
P2860
P304
P356
10.1111/J.1365-2958.2010.07271.X
P407
P577
2010-06-28T00:00:00Z